Trevena to Release First Quarter 2023 Financial Results on May 15, 2023

Trevena

CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company, announced that it will release its financial results for the first quarter ended March 31, 2023, prior to the market open on Monday, May 15, 2023.

The Company will host a conference call and webcast with the investment community at 8:00 a.m. ET that same day, featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Patricia Drake, SVP and Chief Commercial Officer, Mark Demitrack, M.D., SVP and Chief Medical Officer, and Barry Shin, SVP and Chief Financial Officer.

Title: Trevena First Quarter 2023 Financial Results
Conference Call & Webcast
Date: Monday, May 15, 2023
Time: 8:00 a.m. ET
Conference Call Details: Toll-Free: 1-844-825-9789
International: 1-412-317-5180
Conference ID: 10178141
The conference call will be webcast live from the Company’s website and will be available via the following links:
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1610714&tp_key=d4c27074df

https://www.trevena.com/investors/events-presentations/ir-calendar

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s website.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

READ:  TELA Bio to Participate in the Jefferies Global Healthcare Conference